Metagenomics Market Size Booms at 13.55% CAGR, Projects to Climb USD 8.39 Billion by 2034 [Yahoo! Finance]
Revvity, Inc. (RVTY)
Company Research
Source: Yahoo! Finance
Ottawa, Oct. 03, 2025 (GLOBE NEWSWIRE) -- The global metagenomics market size was valued at USD 2.36 billion in 2024 and is predicted to hit around USD 8.39 billion by 2034, rising at a 13.55% CAGR, a study published by Towards Healthcare a sister firm of Precedence Research. The market for metagenomics is seeing a huge growth spike in recent periods because of large-scale applications in multiple domains such as drug discovery, diagnostics, environmental research, antimicrobial resistance, and the development of next-generation sequencing techniques. The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report @ https://www.towardshealthcare.com/download-sample/5771 Key Highlights of the Metagenomics Market By region, North America dominated the metagenomics market in 2024, whereas the Asia Pacific is expected to grow in the forecasted period. By product type, the kits and reagents segment led the metagenomics market in 2024, whereas
Show less
Read more
Impact Snapshot
Event Time:
RVTY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RVTY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RVTY alerts
High impacting Revvity, Inc. news events
Weekly update
A roundup of the hottest topics
RVTY
News
- Revvity (NYSE:RVTY) had its "sell (d)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Revvity (NYSE:RVTY) had its "sell (d)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Revvity to Acquire ACD/Labs to Expand its Signals Software CapabilitiesBusiness Wire
- Revvity (NYSE:RVTY) had its price target raised by analysts at Robert W. Baird from $122.00 to $123.00. They now have an "outperform" rating on the stock.MarketBeat
- Revvity to Present at Upcoming Investor ConferencesBusiness Wire
RVTY
Earnings
- 10/27/25 - Beat
RVTY
Sec Filings
- 11/18/25 - Form NPORT-P
- 11/17/25 - Form SCHEDULE
- 11/14/25 - Form SCHEDULE
- RVTY's page on the SEC website